In a new study from Mayo Clinic, researchers found a suite of ready-to-eat bioactive snacks can meaningfully reduce cholesterol in patients unwilling or unable to take statin drugs.
They evaluated the effect of snacks containing a compendium of functional bioactives (≥5 g fiber, 1,000 mg ω-3 fatty acids, 1,000 mg phytosterols, and 1,800 μmol antioxidants per serving) on fasting low-density lipoprotein (LDL) cholesterol in people unwilling to use or intolerant to statin drugs.
LDL, sometimes called “bad” cholesterol, makes up most of the body’s cholesterol. High levels of LDL cholesterol raise the risk of heart disease and stroke.
For four weeks, 18 men and 36 women used these ready-to-eat snacks as a substitute twice daily.
The researchers found that LDL cholesterol was lowered by 8.80% and total cholesterol dropped by 5.08% with treatment foods.
There were no significant associations between single-nucleotide polymorphisms and outcomes. Compliance with study snacks was 95 percent.
The team says eating snacks containing a compendium of cholesterol-lowering bioactive compounds can rapidly and meaningfully reduce LDL cholesterol in adult patients unable or unwilling to take statin drugs.
If you care about cholesterol, please read studies about why cholesterol-lowering drugs can cause muscle pain and cholesterol-lowering drug that could reduce COVID-19 infection by up to 70%.
For more information about health, please see recent studies that eating walnuts every day could lower bad cholesterol, and prevent heart disease, and results show this small habit can greatly benefit people with slightly high blood pressure and cholesterol.
The study is published in the Journal of Nutrition. One author of the study is Stephen L. Kopecky, M.D.
Copyright © 2022 Knowridge Science Report. All rights reserved.
